Cardio Diagnostics Holdgs Inc.
13F holders, Q3 2024 (September 30)15holders −1
2new positions
3sold out
$0.22avg. 13F price*
At the end of Q3 2024, 15 institutions reported holding Cardio Diagnostics Holdgs Inc. in their 13F filings, down 1 from Q2 2024. 2 opened new positions and 3 sold out. The largest holders were BlackRock, Inc. ($238K), Vanguard Group Inc. ($52K) and Geode Capital Management, LLC ($41K).
- Company
- Cardio Diagnostics Holdgs Inc.
- CUSIP
- 14159C103
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2K |
| Exits | 3 | $85K |
All 13F filers, Q2 2024 → Q3 2024: 21,875 shares bought and 155,239 shares sold, net −133,364 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| BlackRock, Inc. | 0.00% | — | 1,067,062 | $238K |
| Vanguard Group Inc. | 0.00% | No change | 232,139 | $52K |
| Geode Capital Management, LLC | 0.00% | Add +5.7% | 184,409 | $41K |
| Northern Trust Corp. | 0.00% | No change | 48,619 | $11K |
| State Street Corp. | 0.00% | No change | 43,500 | $10K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 40,500 | $9K |
| LPL Financial LLC | 0.00% | No change | 15,199 | $3K |
| Endowment Wealth Management, Inc. | 0.00% | No change | 14,307 | $3K |
| HRT Financial LP | 0.00% | New | 11,009 | $2K |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 8,101 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -15.7% | 4,847 | $1K |
| Wolverine Asset Management LLC | 0.00% | No change | 3,777 | $842 |
| Osaic Holdings, Inc. | 0.00% | No change | 3,150 | $693 |
| Morgan Stanley | 0.00% | New | 1,000 | $223 |
| Bank of America Corp. | 0.00% | Add +7.3% | 162 | $36 |
"% of holder's portfolio" is CARDIO DIAGNOSTICS HOLDGS IN's weight in each manager's 13F, not the share of Cardio Diagnostics Holdgs Inc. the manager owns.